Publication

Seattle Q2 2025 Life Sciences Market Overview

Article

Contacts & Related Research

Image treatment

Market Highlights

  • VerAvanti, a MedTech company, raised $31.5 million, the largest life sciences VC funding in Seattle this quarter, to advance its imaging scopes for stroke and heart attack prevention.
  • Curi Bio has officially opened its 13,942-square-foot (sf) global headquarters at 201 Elliott Avenue West, supporting the company’s ongoing expansion and advancements in preclinical drug development.
  • Venture capital (VC) funding in Seattle has reached $906.7 million year-to-date, surpassing the total funding for 2024. This positions 2025 to be one of the strongest years for VC investment in the region.

Read the full report